[Malignant bone pain].
Bone pain is one of the most frequent causes of pain in patients with cancer, and the levels of metastases and bone pain are not directly correlated. Nociceptors in the periosteum are probably stimulated by halisteresis or by inflammatory oedema leading to an increase in the intraosseous pressure. Some authors believe that the nociceptors in bone are mediated via intraosseous mechanoreceptors in the bone-matrix. At a low pain level the initial treatment is acetylsalicylic acid, paracetamol or other nonsteroidal antiinflammatory drugs. At increasing pain level initial doses of oral opioids are added. In severe bone pain, where conventional therapy seems difficult, opioids are administered by invasive techniques. In localised bone pain palliative radiation is the first treatment of choice. Corticosteroids induce an analgetic effect indirectly by reducing the inflammatory oedema, inhibiting the synthesis of prostaglandins and may inhibit excitatory nerve fibres. Endocrine treatment, calcitonin and biophosphonates have shown a documented pain-relieving effect in patients with disseminated breast and prostate cancer. Chemotherapy has shown a pain-relieving effect in patients with disseminated breast cancer, surgical intervention is used in stabilizing osteolytic bones before or after a fracture ensuring a reasonable relief of pain.
Thomsen
C B
CB
Tvaerfaglige Smertecenter, Rigshospitalet.
Crawford
M E
ME
Sjøgren
P
P
D000701:Analgesics, Opioid / Q000008:administration & dosage*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001859:Bone Neoplasms / Q000503:physiopathology / Q000556:secondary*; D001842:Bone and Bones / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D009619:Nociceptors / Q000187:drug effects; D010148:Intractable Pain / Q000188:drug therapy* / Q000503:physiopathology; D010166:Palliative Care
D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal
Maligne knoglesmerter.